Current approaches to evidence collection are leaving valuable research questions unanswered
Across the therapy area lifecycle there are many questions, that if answered could accelerate the development and adoption of treatments that will improve outcomes for patients. However the main routes to evidence creation are currently leaving valuable research questions unanswered.
70
%
of patients live more than 2 hours from a research site
2
/3
of studies delayed or cancelled due to slow enrollment
uMed’s ACCESS Cohorts are addressing evidence gaps & accelerating research
Smart Cohorts powered by our ACCESS Research Platform
By leveraging uMed’s ACCESS Research Platform which is embedded across a global network of healthcare institutions, researchers can access custom patient data and insights derived from the remote collection of electronic health records, clinical outcomes, patient-generated data and biosamples.
Making research accessible to the wider population
Untapped patient cohorts that better represent the total population
REC approved protocol programmes
Credible clinical evidence that will influence clinical practice & regulatory decisions
Answer new research questions at speed
Without the cost and resource of setting up from scratch
Access exclusive data with real-time integrated clinical outcomes
Combining electronic health records, physician reported outcomes, and patient generated data
Access deeply characterized consented patient cohorts
That exactly match your research requirements
Master protocol embedded across a global healthcare network
Providing access for/to over 10m patients across the UK & US
We are working with top institutions & vendors across the US, UK & Canada
